Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether Cordyceps Sinensis can prevent recurrence in patients with Mycobacterium avium complex pulmonary disease, and rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cordyceps Sinensis (Cordyceps sinensis)

Snippet

Sponsor: Bin Cao | Conditions: Mycobacterium Avium Complex Pulmonary Disease | Phase 4 | Status: RECRUITING